Source – Pregabalin prescribing patterns in Australian general practice, 2012–2018: a cross-sectional study[/caption]
National Medicines Symposium 2024 speakers (L to R): Steve Waller, Professor Jennifer Martin, Professor Libby Roughead, Tegan Taylor[/caption]
This CPD activity is sponsored by Reckitt. All content is the true, accurate and independent opinion of the speakers and the views expressed are entirely their own.[/caption]
How should pharmacists report incidents?
All incidents should be reported, no matter how minor. Here’s how pharmacists can best approach this process.
New safety alert for co-prescribing opioids and gabapentinoids
Gabapentinoids and opioids are commonly co-prescribed, whether to treat acute pain post-surgery or to address chronic pain. Here’s how to mitigate risk when these medicines are combined.
Public health leaders receive Queen’s Birthday honours
Pharmacists and public health leaders were honoured for their services to the community in this year’s Queen’s Birthday honours.
Allergic rhinitis and COVID-19: advice for pharmacists
At a time when it is vital to identify and treat individuals infected with the COVID-19 virus, it is also important to recognise and manage the symptoms of allergic rhinitis.
Pharmacist with history of anaphylaxis gets COVID-19 vaccine
Pharmacist immuniser Vanessa Lange MPS has a history of anaphylactic reactions to vaccines. She spoke with Australian Pharmacist about her decision to get the COVID-19 vaccine and using her experience to help vaccine-hesitant patients.
Advancing your impact in diabetes education
Accredited pharmacist and Credentialed Diabetes Educator Angelica Rostov details how pharmacists can advance their diabetes education.
The following changes are now in place for those...
